Patent holdings for IPC class A61K 31/17

Total number of patents in this class: 1341

10-year publication summary

83
106
109
105
102
105
119
78
81
14
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Allergan, Inc.
2600
33
The Regents of the University of California
18943
27
Bristol-myers Squibb Company
5080
21
Hope Medical Enterprises, Inc.
49
11
Lantern Pharma Inc.
62
11
The Regents of the University of Michigan
4409
10
Adamas Pharma, LLC
49
10
Royalty Security, LLC
24
10
Arete Therapeutics, Inc.
23
9
Galderma Research & Development
440
9
Neoculi Pty Ltd
18
9
Remedy Pharmaceuticals, Inc.
36
9
The Board of Trustees of the Leland Stanford Junior University
6054
8
Duke University
2872
8
Xeno Biosciences Inc., DBA Xeno Biosciences
10
8
Société des Produits Nestlé S.A.
9672
7
The Board of Trustees of the University of Illinois
2623
7
Assistance Publique-hopitaux de Paris (aphp)
427
7
H. Lee Moffitt Cancer Center and Research Institute, Inc.
829
7
Memorial Sloan-Kettering Cancer Center
1789
7
Other owners 1113